| Literature DB >> 34199972 |
Nawaporn Jingjit1, Sutima Preeprem2, Komwit Surachat3,4, Pimonsri Mittraparp-Arthorn1,4.
Abstract
Vibrio parahaemolyticus is one of the significant seafood-borne pathogens causing gastroenteritis in humans. Clustered regularly interspaced short palindromic repeats (CRISPR) are commonly detected in the genomes of V. parahaemolyticus and the polymorphism of CRISPR patterns has been applied as a genetic marker for tracking its evolution. In this work, a total of 15 pandemic and 36 non-pandemic V. parahaemolyticus isolates obtained from seafood between 2000 and 2012 were characterized based on hemolytic activity, antimicrobial susceptibility, and CRISPR elements. The results showed that 15/17 of the V. parahaemolyticus seafood isolates carrying the thermostable direct hemolysin gene (tdh+) were Kanagawa phenomenon (KP) positive. The Multiple Antibiotic Resistance (MAR) index ranged between 0.1 and 0.4, and 45% of the isolates have an MAR index ≥ 0.2. A total of 19 isolates were positive for CRISPR detection, including all tdh+ trh- isolates, two of tdh- trh+, and each of tdh+ trh+ and tdh- trh-. Four spacer types (Sp1 to Sp4) were identified, and CRISPR-positive isolates had at least one type of spacer homolog to the region of Vibrio alginolyticus megaplasmid. It is of interest that a specific CRISPR profile and spacer sequence type was observed with correlations to the hemolysin genotype (tdh/trh). Thus, these provide essential data on the exposure of foreign genetic elements and indicate shared ancestry within different genotypes of V. parahaemolyticus isolates.Entities:
Keywords: CRISPR; V. parahaemolyticus; evolution; hemolysin gene; seafood
Year: 2021 PMID: 34199972 PMCID: PMC8226915 DOI: 10.3390/microorganisms9061220
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
V. parahaemolyticus isolates used in this study and their characteristics.
| Hemolysin | Isolates | Year of | Source | GS-PCR * | Kanagawa | MAR * | CRISPR-PCR |
|---|---|---|---|---|---|---|---|
| Seafood isolates | |||||||
| PSU166 | 2000 | Hard clam | + | + | 0.2 | + | |
| PSU358 | 2001 | Mussel | + | + | 0.2 | + | |
| PSU360 | + | + | 0.2 | + | |||
| PSU434 | + | + | 0.2 | + | |||
| PSU474 | + | + | 0.2 | + | |||
| PSU476 | + | + | 0.1 | + | |||
| PSU479 | 2002 | Hard clam | + | + | 0.1 | + | |
| PSU579 | Cockle | + | + | 0.2 | + | ||
| PSU635 | Mussel | + | + | 0.3 | + | ||
| PSU637 | Mussel | + | + | 0.2 | + | ||
| PSU638 | Mussel | + | + | 0.2 | + | ||
| PSU3249 | 2006 | Mussel | + | − | 0.1 | + | |
| PSU4067 | 2008 | Cockle | + | + | 0.1 | + | |
| PSU4888 | 2010 | Hard clam | + | + | 0.1 | + | |
| PSU5382 | 2012 | Shellfish | + | + | 0.1 | + | |
| PSU3819 | 2007 | Crab | − | − | 0.2 | + | |
| − | − | 0.2 | + | ||||
| PSU5124 | 2011 | Shrimp | − | − | 0.1 | − | |
| PSU582 | 2002 | Cockle | − | + | 0.2 | + | |
| PSU4413 | 2008 | Cockle | − | − | 0.1 | − | |
| PSU513 | 2002 | Cockle | − | − | 0.1 | − | |
| − | − | 0.1 | − | ||||
| − | − | 0.1 | + | ||||
| PSU811 | 2003 | Mussel | − | − | 0.1 | − | |
| PSU2463 | 2005 | Cockle | − | − | 0.2 | − | |
| − | − | 0.2 | − | ||||
| − | − | 0.2 | − | ||||
| PSU3103 | 2006 | Hard clam | − | − | 0.1 | − | |
| PSU3858 | 2008 | Octopus | − | − | 0.4 | − | |
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.2 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| PSU4415 | 2009 | Cockle | − | − | 0.1 | − | |
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.4 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.1 | − | ||||
| PSU4869 | 2010 | Mussel | − | − | 0.2 | − | |
| − | − | 0.2 | − | ||||
| − | − | 0.1 | − | ||||
| − | − | 0.2 | − | ||||
| PSU5379 | 2012 | Shellfish | − | − | 0.1 | − | |
| Clinical isolates | |||||||
| PSU3872 | 2008 | Clinical | + | + | 0.3 | + | |
| PSU3949 | 2008 | Clinical | + | + | 0.2 | + | |
| PSU5126 | 2011 | Clinical | + | + | 0.1 | + | |
| ATCC17802 | 1965 | Clinical | − | − | 0.2 | − |
* GS-PCR, Group-Specific PCR; MAR, Multiple Antibiotic Resistance.
Figure 1Quantitative analysis of the hemolytic activity of V. parahaemolyticus seafood isolates. Each point shows the mean value from duplicate experiments. Median values are shown by a horizontal line.
Antimicrobial susceptibility patterns of V. parahaemolyticus isolates from seafood sources.
| Antimicrobial Drugs | No. of Isolates (%) | ||
|---|---|---|---|
| Susceptible | Intermediate | Resistant | |
| Ampicillin | 0 | 0 | 51 (100) |
| Gentamycin | 12 (23.5) | 39 (76.5) | 0 |
| Erythromycin | 0 | 29 (56.9) | 22 (43.1) |
| Sulfonamide | 49 (96) | 1 (2) | 1 (2) |
| Tetracycline | 49 (96) | 1 (2) | 1 (2) |
| Ciprofloxacin | 12 (23.5) | 38 (74.5) | 1 (2) |
| Trimethoprim/sulfamethoxazole | 36 (70.6) | 13 (25.5) | 2 (3.9) |
| Chloramphenicol | 51 (100) | 0 | 0 |
| Norfloxacin | 34 (66.7) | 16 (31.3) | 1 (2) |
Characteristics of CRISPR repeat sequences and pattern in CRISPR-positive V. parahaemolyticus isolates.
| Hemolysin | Type | Direct Repeats (DRs) Sequences * | No. of DRs | No. of Spacers | CRISPR Locus Pattern (bp) * |
|---|---|---|---|---|---|
| Seafood isolates | |||||
| Typical repeat | GTGAACTGCCGAATAGGTAGCTGATAAT | 3 | 2 (1, 4) | ||
| Typical repeat | GTGAACTGCCGAATAGGTAGCTGATAAT | 3 | 2 (2, 4) | ||
| Typical repeat | GTGAACTGCCGAATAGGTAGCTGATAAT | 2 | 1 (3) | ||
| Typical repeat | GTGAACTGCCGAATAGGTAGCTGATAAT | 2 | 1 (1) | ||
| Clinical isolates | |||||
| Typical repeat | GTGAACTGCCGAATAGGTAGCTGATAAT | 3 | 2 (1, 4) |
* Underline indicates mutation compared to typical repeat sequence, italic indicates the direct repeats (CDRs) sequence length and bold indicates the spacer length.
Figure 2The secondary structures of four CRISPR repeats found in V. parahaemolyticus isolates. Predicted secondary structures were obtained using RNA fold. The dashed boxes indicate the sequence differences between typical repeat (A), and terminal repeat of tdh+ trh− (B), tdh+ trh+ and tdh+ trh− (C), and tdh− trh− (D) V. parahaemolyticus isolates, respectively.
Homology analysis of V. parahaemolyticus spacers against foreign genetic elements.
| Spacer Type (Length) | Spacer Sequences (5′ to 3′) | Spacer Homology | Query Cover/ | Accession Number/ |
|---|---|---|---|---|
| Sp1 (32) | GAGATACCACAAGCTCAAGCAGATGCTAACAG | 93/96.7 | CP017915.1/ | |
| Sp2 (31) | TCATTCTCACGATCTAATTACAGTTGGTCAC | 93/100 | CP017915.1/ | |
| Sp3 (31) | TGCAGACAAACAAAGAGCCATCGACGAGTGC | 100/87.1 | CP017915.1/ | |
| Sp4 (31) | AGTCGGTCAACTGAGAATACGTTGTTGCCAA | - | - | - |
Homology analysis of the Sp1 to Sp4 spacers against public genomes of V. parahaemolyticus.
| Spacer Type | Isolates | Hemolysin | Sources * | Identities (%) | E-Value | Accession Number |
|---|---|---|---|---|---|---|
| Sp1 | Clinical, Japan | 100 | 2 × 10−8 | BA000032.2 | ||
| Shrimp, China | 100 | 2 × 10−8 | CP031782.1 | |||
| Clinical, India | 100 | 2 × 10−8 | CP020428.2 | |||
| Environment, India | 96.88 | 1 × 10−6 | CP003973.1 | |||
| Clinical, South Korea | 100 | 1 × 10−6 | CP023486.1 | |||
| Sp2 | Clam, India | 100 | 7 × 10−8 | MG765521.1 | ||
| Oyster, India | 100 | 7 × 10−8 | MG765520.1 | |||
| Shrimp, India | 100 | 9 × 10−7 | MG765517.1 | |||
| Sp3 | Clinical, USA | 100 | 7 × 10−8 | CP045795.1 | ||
| Clinical, USA | 100 | 7 × 10−8 | CP023247.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP011885.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | MF066646.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP022472.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP044070.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP026042.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046777.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046780.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046753.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046827.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046809.1 | |||
| Clinical, USA | 100 | 7 × 10−8 | CP046784.1 | |||
| Sp4 | Clinical, Japan | 100 | 7 × 10−8 | BA000032.2 | ||
| Shrimp, China | 100 | 7 × 10−8 | CP031782.1 | |||
| Clinical, India | 100 | 7 × 10−8 | CP020428.2 | |||
| Environment, Bangladesh | 100 | 7 × 10−8 | CP003973.1 | |||
| Clinical, South Korea | 100 | 7 × 10−8 | CP023486.1 | |||
| Oyster, India | 100 | 7 × 10−8 | MG765520.1 | |||
| Oyster, India | 100 | 7 × 10−8 | MG765518.1 | |||
| Shrimp, India | 100 | 7 × 10−8 | MG765517.1 |
* Hemolysin genotypes and sources were indicated based on the results obtained by database search and/or previous publications. Unk—unknown.
Figure 3Distribution of protospacers along the representative plasmid pL300 of V. alginolyticus K08M3. The plasmid map is drawn from the GenBank entry CP017915.1 and ORFs are shown as arrows. Red arrows indicate the position of spacer-matching sequences (Sp1 to Sp3) found in the CRISPR region of V. parahaemolyticus analyzed in this study.
Figure 4A zoomed-in view of the progressiveMauve alignment between V. alginolyticus pL300 megaplasmid (top) and other plasmids from the blast hit results. The protospacer regions are annotated and shown in the red vertical bar. Homologous genomes are indicated by the connected-with-lines collinear blocks.
Figure 5Dendrogram of the 19 CRISPR-positive V. parahaemolyticus seafood isolates. The maximum likelihood method was used for constructing the phylogenetic tree. The bar represents a 5% dissimilarity between the two sequences. Colors within the squares correspond to the presence of spacer and virulence genes.